Risperidone treatment of neuroleptic-induced tardive extrapyramidal symptoms

By Suenaga Takami   Tawara Yasutaka   Goto Shinichiro   Kouhata Shin-Ichi   Kagaya Ariyuki   Horiguchi Jun   Yamanaka Yusuke   Yamawaki Shigeto  

International Journal of Psychiatry in Clinical Practice, Vol. 4, Iss. 3, 2000-09 ,pp. : 241-243

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Mu opioid receptor gene polymorphism and neuroleptic-induced tardive dyskinesia in patients with schizophrenia

By Tan E.-C.   Chong S.-A.   Mahendran R.   Tan C.H.   Teo Y.-Y.  

Schizophrenia Research, Vol. 65, Iss. 1, 2003-12 ,pp. : 61-63

Elsevier

Access to resources Recommend Favorite

Non-neuroleptic approaches to treating negative symptoms in schizophrenia

By Möller Hans-Jürgen  

European Archives of Psychiatry and Clinical Neuroscience, Vol. 254, Iss. 2, 2004-04 ,pp. : 108-116

Springer Publishing Company

Access to resources Recommend Favorite

Neuroleptic-induced dystonia: incidence and risk factors

By Ballerini M.   Bellini S.   Niccolai C.   Pieroni V.   Ferrara M.  

European Psychiatry, Vol. 17, Iss. 6, 2002-10 ,pp. : 366-368

Elsevier

Access to resources Recommend Favorite

Low-dose neuroleptic therapy and extrapyramidal side effects in schizophrenia: an effect size analysis

By Barbui C.   Saraceno B.  

European Psychiatry, Vol. 11, Iss. 8, 1996-01 ,pp. : 412-415

Elsevier

Access to resources Recommend Favorite